Lipum AB (publ) (LIPUM.ST)

SEK 13.3

(-1.48%)

Eps Summary of Lipum AB (publ)

  • Lipum AB (publ)'s latest annual eps in 2023 was -4.45 SEK , up 26.08% from previous year.
  • Lipum AB (publ)'s latest quarterly eps in 2024 Q3 was -0.08 SEK , up 92.73% from previous quarter.
  • Lipum AB (publ) reported an annual eps of -6.02 SEK in 2022, up 52.3% from previous year.
  • Lipum AB (publ) reported an annual eps of -12.62 SEK in 2021, down -36.58% from previous year.
  • Lipum AB (publ) reported a quarterly eps of -0.08 SEK for 2024 Q3, up 92.73% from previous quarter.
  • Lipum AB (publ) reported a quarterly eps of -1.09 SEK for 2024 Q2, down -15.96% from previous quarter.

Annual Eps Chart of Lipum AB (publ) (2023 - 2017)

Historical Annual Eps of Lipum AB (publ) (2023 - 2017)

Year Eps Eps Growth
2023 -4.45 SEK 26.08%
2022 -6.02 SEK 52.3%
2021 -12.62 SEK -36.58%
2020 -9.24 SEK -369.04%
2019 -1.97 SEK -68.38%
2018 -1.17 SEK -6.27%
2017 -1.10 SEK 0.0%

Peer Eps Comparison of Lipum AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -709.091%
Ziccum AB (publ) -1.54 SEK -188.961%
Modus Therapeutics Holding AB (publ) -1.01 SEK -340.594%
BioArctic AB (publ) 2.60 SEK 271.154%
Sprint Bioscience AB (publ) -0.01 SEK -70534.921%
Mendus AB (publ) -4.40 SEK -1.136%
Genovis AB (publ.) 0.94 SEK 573.404%
Intervacc AB (publ) -1.69 SEK -163.314%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -1922.727%
Active Biotech AB (publ) -0.17 SEK -2517.647%
Magle Chemoswed Holding AB (publ) 1.13 SEK 493.805%
Bio-Works Technologies AB (publ) -1.57 SEK -183.439%
Aptahem AB (publ) -0.05 SEK -9113.251%
Vicore Pharma Holding AB (publ) -3.22 SEK -38.199%
Kancera AB (publ) -0.80 SEK -456.25%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 55.276%
Fluicell AB (publ) -0.24 SEK -1754.167%
Saniona AB (publ) -1.29 SEK -244.961%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -2242.105%
Biovica International AB (publ) -2.14 SEK -107.944%
Spago Nanomedical AB (publ) -0.43 SEK -934.884%
AcouSort AB (publ) -1.29 SEK -244.961%
Xintela AB (publ) -0.13 SEK -3323.077%
Abliva AB (publ) -0.09 SEK -4822.566%
Egetis Therapeutics AB (publ) -1.27 SEK -250.394%
Karolinska Development AB (publ) 0.02 SEK 22350.0%
OncoZenge AB (publ) -1.36 SEK -227.206%
Amniotics AB (publ) -0.01 SEK -40354.545%
2cureX AB (publ) -1.85 SEK -140.541%
CombiGene AB (publ) -1.80 SEK -147.222%
Asarina Pharma AB (publ) -0.57 SEK -680.702%
Calliditas Therapeutics AB (publ) -8.69 SEK 48.792%
Camurus AB (publ) 7.78 SEK 157.198%
Corline Biomedical AB -0.08 SEK -5185.036%
IRLAB Therapeutics AB (publ) -3.43 SEK -29.738%
Isofol Medical AB (publ) -0.23 SEK -1834.783%
I-Tech AB 1.70 SEK 361.765%
Hansa Biopharma AB (publ) -15.83 SEK 71.889%
Cyxone AB (publ) -0.22 SEK -1922.727%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK -124.747%
Biosergen AB -0.60 SEK -641.667%
Cantargia AB (publ) -1.65 SEK -169.697%
NextCell Pharma AB -1.03 SEK -332.039%
Xspray Pharma AB (publ) -6.76 SEK 34.172%
Elicera Therapeutics AB (publ) -0.83 SEK -436.145%
Nanologica AB (publ) -2.05 SEK -117.073%
SynAct Pharma AB -6.64 SEK 32.982%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -1611.538%
Stayble Therapeutics AB (publ) -0.92 SEK -383.696%
LIDDS AB (publ) -0.63 SEK -606.349%
BioInvent International AB (publ) -5.02 SEK 11.355%
Alzinova AB (publ) -0.41 SEK -985.366%
Oncopeptides AB (publ) -1.96 SEK -127.041%
Pila Pharma AB (publ) -0.47 SEK -846.809%
Guard Therapeutics International AB (publ) -11.26 SEK 60.48%
Scandinavian ChemoTech AB (publ) -1.13 SEK -293.805%
Simris Alg AB (publ) -0.16 SEK -2681.25%
Diamyd Medical AB (publ) -1.60 SEK -178.125%
Xbrane Biopharma AB (publ) -1.27 SEK -250.394%
Ascelia Pharma AB (publ) -3.24 SEK -37.346%
Diagonal Bio AB (publ) -0.32 SEK -1290.625%